Arrowstreet Capital’s Invacare Corporation IVC Stock Holding History

Arrowstreet Capital’s Portfolio IVC Stock Details IVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-285,912	Closed	-$778K	–	1619
2021 Q4	$778K	Buy	+285,912	New	+$1.05M	﹤0.01%	1209
2021 Q1	–	Sell	-135,819	Closed	-$1.22M	–	2637
2020 Q4	$1.22M	Buy	135,819 +87,929	+184%	+$731K	﹤0.01%	1763
2020 Q3	$360K	Buy	+47,890	New	+$332K	﹤0.01%	2104
2016 Q2	–	Sell	-326,545	Closed	-$4.3M	–	1557
2016 Q1	$4.3M	Buy	326,545 +63,756	+24%	+$904K	0.02%	587
2015 Q4	$4.57M	Sell	262,789 -1,400	-0.5%	-$25.3K	0.02%	571
2015 Q3	$3.82M	Buy	264,189 +9,814	+4%	+$172K	0.02%	603
2015 Q2	$5.5M	Buy	254,375 +117,774	+86%	+$2.49M	0.03%	402
2015 Q1	$2.65M	Sell	136,601 -49,706	-27%	-$861K	0.02%	542
2014 Q4	$3.12M	Buy	186,307 +63,961	+52%	+$971K	0.02%	590
2014 Q3	$1.45M	Buy	122,346 +4,401	+4%	+$67.1K	0.01%	659
2014 Q2	$2.17M	Buy	117,945 +45,659	+63%	+$775K	0.01%	574
2014 Q1	$1.38M	Buy	72,286 +60,863	+533%	+$1.25M	0.01%	749
2013 Q4	$265K	Buy	+11,423	New	+$237K	﹤0.01%	1074

Other funds holding IVC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RCM

Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

NRC

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Arrowstreet Capital's IVC Position: Q1 2022 in Review

Arrowstreet Capital sold out of Invacare Corporation (IVC) in Q1 2022, closing a stake of 285,912 shares — an estimated $778K sold.

Arrowstreet Capital first reported a position in IVC in Q4 2013 and held it in 13 quarters. The position peaked at $5.5M in Q2 2015. 109 funds tracked by Wall St. Rank hold IVC as of Q1 2022.

Arrowstreet Capital reported no remaining Invacare Corporation position as of Q1 2022 after selling out during the quarter.
Arrowstreet Capital sold 285,912 Invacare Corporation shares in Q1 2022, an estimated $778K.
Arrowstreet Capital first reported a position in Invacare Corporation in Q4 2013 and held it in 13 quarters.
Arrowstreet Capital's Invacare Corporation position peaked at $5.5M in Q2 2015.
109 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2022.

Based on Arrowstreet Capital's 13F filing for Q1 2022, filed 13 May 2022.